Skip to main content
Log in

Neoplastic cell inhibition with new ether lipid analogs

  • Published:
Lipids

Abstract

Bioactive phospholipid analogs of platelet-activating factor (PAF) represent a new approach to cancer chemotherapy. Various modifications of the basic structure of PAF lead to different ether lipid (EL) analogs. Data from the evaluation of thioalkyl and amidoalkyl glycerophosphocholine and of glycerophosphoinositol EL analogs against different experimental tumors in vitro (HL60 and K562 human leukemia cells, BG1 and BG3 ovarian adenocarcinomas) are presented. Exclusion of trypan blue after short exposure to the drugs determined cytotoxicity, and a soft agarose clonogenic assay measured the ability of the analogs to inhibit tumor cell proliferation. The thioalkyl EL are very active against the cell lines using both end points, and the amidoalkyl EL showed efficacy against the leukemic cell lines, whereas the phosphoinositol EL are active only at high concentrations. Combined use of EL analogs, which are membrane-interactive, with classical DNA-interactive chemotherapeutic drugs revealed that the combinations have additive antiproliferative effects. These results are promising leads in the development of the anticancer potential of ether lipid analogs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Berdel, W.E., Andreesen, R., and Munder, P.G. (1985) inPhospholipids and Cellular Regulation (Kuo, J.F., ed.) Vol. II, pp. 41–73, CRC Press, Boca Raton, FL.

    Google Scholar 

  2. Munder, P.G., Modolell, M., Bausert, W., Oettgen, H.F., and Westphal, O. (1981) inAugmenting Agents in Cancer Therapy (Hersh, E.M., ed.) pp. 441–458, Raven Press, New York.

    Google Scholar 

  3. Berdel, W.E., Bausert, W.R.E., Fink, U., Rastetter, J., and Munder, P.G. (1981)Anticancer Res. 1, 345–352.

    PubMed  CAS  Google Scholar 

  4. Berdel, W.E., Fink, U., Egger, B., Reichert, A., Munder, P.G., and Rastetter, J. (1981)Anticancer Res. 1, 135–140.

    PubMed  CAS  Google Scholar 

  5. Honma, Y., Kasukabe, T., Hozumi, M., Tsushima, S., and Nomura, H. (1981)Cancer Res. 41, 3211–3216.

    PubMed  CAS  Google Scholar 

  6. Berdel, W.E., Von Hoff, D.D., Unger, C., Schick, H.D., Fink, U., Richter, A., Eibl, H., and Rastetter, J. (1986)Lipids 21, 301–304.

    Article  PubMed  CAS  Google Scholar 

  7. Herrman, D.B.J., Bosies, E., Bicker, U., Gall, R., Pahlke, W., and Boerner, D. (1986)Abstr. Second International Conference on Platelet-Activating Factor and Structurally Related Alkyl Ether Lipids, Gatlinburg, TN, p. 112.

  8. Modest, E.J., Daniel, L.W., Wykle, R.L., Berens, M.E., Piantadosi, C., Surles, J.R., and Morris-Natschke, S. (1987) inNew Avenues in Developmental Cancer Chemotherapy (Harrap, K., and Connors, T., eds.) Bristol-Myers Cancer Symposia, Vol. 8, pp. 387–400, Academic Press, New York.

    Google Scholar 

  9. Morris-Natschke, S., Surles, J.R., Daniel, L.W., Berens, M.E., Modest, E.J., and Piantadosi, C. (1986)J. Med. Chem. 29, 2114–2117.

    Article  PubMed  CAS  Google Scholar 

  10. Modest, E.J., Daniel, L.W., Berens, M.E., Morris-Natschke, S., Surles, J.R., and Piantadosi, C. (1986)Proc. Am. Assoc. Cancer Res. 27, 275.

    Google Scholar 

  11. Modest, E.J., Noseda, A., Daniel, L.W., Berens, M.E., Morris-Natschke, S., and Piantadosi, C. (1986)Abstr. Second International Conference on Platelet-Activating Factor and Structurally Related Alkyl Ether Lipids, Gatlinburg TN, p. 54.

  12. Ishaq, K.S., Capobianco, M., Piantadosi, C., Noseda, A., Modest, E.J., and Snyder, F. (1986)Abstr. Second International Conference on Platelet-Activating Factor and Structurally Related Alkyl Ether Lipids, Gatlinburg, TN, p. 157.

  13. Berdel, W.E., Schlehe, H., Fink, U., Emmerich, B., Maubach, P.A., Emslander, H.P., Daum, S., and Rastetter, J. (1982)Cancer 50, 2011–2015.

    Article  PubMed  CAS  Google Scholar 

  14. Herrman, D.B.J. (1986)Abstr. Second International Conference on Platelet Activating Factor and Structurally Related Alkyl Ether Lipids, Gatlinburg, TN, p. 53.

  15. Marx, M.H., Piantadosi, C., Wykle, R., O’Flaherty, J.T., Modest, E.J., and Daniel, L.W. (1985)Abstr. 20th Annual Southeastern Regional Lipid Conference, Cashiers, NC.

  16. Welander, C.E., Morgan, T.M., Homesley, H.D., Trotta, P.P., and Spiegel, R.J. (1985)Int. J. Cancer 35, 721–729.

    PubMed  CAS  Google Scholar 

  17. Chen, R.T. (1977)Exp. Cell Res. 104, 255–262.

    Article  PubMed  CAS  Google Scholar 

  18. Adams, R.L.P. (1980) inLaboratory Techniques in Biochemistry and Molecular Biology (Work, T.S., and Burdon, R.H., eds.) Elsevier, Amsterdam.

    Google Scholar 

  19. Hamburger, A.W., and Salmon, S.E. (1977)Science 197, 461–463.

    Article  PubMed  CAS  Google Scholar 

  20. Salmon, S.E., Young, L., Lebowitz, J., Thomson, S., Einsphar, J., Tong, T., and Moon, T.E. (1984)Int. J. Cell. Cloning 2, 142–160.

    Article  PubMed  CAS  Google Scholar 

  21. Tidwell, T., Guzman, G., and Vogler, W.R. (1981)Blood 57, 794–797.

    PubMed  CAS  Google Scholar 

  22. Roos, G., and Berdel, W.E. (1986)Leuk. Res. 10, 195–202.

    Article  PubMed  CAS  Google Scholar 

  23. Hong, C.I., Seung-Ho, A., Buchheit, D.J., Nechaev, A., Kiristis, A.J., West, R.C., and Berdel, W.E. (1986)J. Med. Chem. 29, 2038–2044.

    Article  PubMed  CAS  Google Scholar 

  24. Berdel, W.E., Schick, H.D., Fink, U., Reichert, A., Ulm, K., and Rastetter, J. (1985)Cancer Res. 45, 1206–1213.

    PubMed  CAS  Google Scholar 

  25. Berdel, W.E., Fromm, M., Fink, U., Pahlke, W., Bicker, U., Reichert, A., and Rastetter, J. (1983)Cancer Res. 43, 5538–5543.

    PubMed  CAS  Google Scholar 

  26. Hoffman, D.R., Hajdu, J., and Snyder, F. (1984)Blood 63, 545–552.

    PubMed  CAS  Google Scholar 

  27. Lee, T-C., and Snyder, F. (1985) inPhospholipids and Cellular Regulation (Kuo, J.F., ed.) Vol. II, pp. 1–39, CRC Press, Boca Raton, FL.

    Google Scholar 

  28. Lee, T-C., Blank, M.L., Fitzgerald, V., and Snyder, F. (1981)Arch. Biochem. Biophys. 208, 353–357.

    Article  PubMed  CAS  Google Scholar 

  29. Hoffman, D.R., Hoffman, L.H., and Snyder, F. (1986)Cancer Res. 46, 5803–5809.

    PubMed  CAS  Google Scholar 

  30. Storme, G.A., Berdel, W.E., van Blitterswijk, W.J., Bruyneel, E.A., De Bruyne, G.K., and Mareel, M.M. (1985)Cancer Res. 45, 351–357.

    PubMed  CAS  Google Scholar 

  31. Record, M., Hoffman, D.R., and Snyder, F. (1986)Proc. Am. Assoc. Cancer Res. 27, 14.

    Google Scholar 

  32. Weltzien, H.U. (1979)Biochim. Biophys. Acta 559, 259–287.

    PubMed  CAS  Google Scholar 

  33. Noseda, A., White, J.G., and Modest, E.J. (1987)Proc. Am. Assoc. Cancer Res. 28, 13.

    Google Scholar 

  34. Andreesen, R., Modolell, M., Oepke, G.H.F., Common, H., Lohr, G.W., and Munder, P.G. (1982)Anticancer Res. 2, 95–100.

    PubMed  CAS  Google Scholar 

  35. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y. (1981)Cancer Lett. 13, 133–137.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Noseda, A., Berens, M.E., Piantadosi, C. et al. Neoplastic cell inhibition with new ether lipid analogs. Lipids 22, 878–883 (1987). https://doi.org/10.1007/BF02535548

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02535548

Keywords

Navigation